Trilobatin as an <scp>HIV</scp>‐1 entry inhibitor targeting the <scp>HIV</scp>‐1 Gp41 envelope

Shuwen Yin(Guangdong Pharmaceutical University), Li Lin(Guangdong Pharmaceutical University)
FEBS Letters
May 26, 2018
Cited by 30


Related Papers